Hepatitis C genotype 4: The past, present, and future

doi:10.4254/wjh.v7.i28.2792

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11672)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

1052

WORD

539

HTML

6589

Figures (1-3)

162

Tables (1-1)

128

Sum=8470

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1221

Download

1981

Sum=3202

Dec 8, 2015 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (37)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Hepatol. Dec 8, 2015; 7(28): 2792-2810
Published online Dec 8, 2015. doi: 10.4254/wjh.v7.i28.2792

Full Size Figure Download Figure

Figure 3 Results of hepatitis C virus genotype-4 treatments with pegylated-interferon and ribavirin: 24 wk vs 48 wk. (P = not reported) (P = 0.001) (P = 0.006) showing far less sustained virologic response rates with 24 wk of therapy[132-134].

Citation: Abdel-Ghaffar TY, Sira MM, El Naghi S. Hepatitis C genotype 4: The past, present, and future. World J Hepatol 2015; 7(28): 2792-2810
URL: https://www.wjgnet.com/1948-5182/full/v7/i28/2792.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i28.2792